Immunoadjuvant therapy for lung cancer. A critical review.
D000951:Antigens, Neoplasm / Q000276:immunology; D001500:BCG Vaccine / Q000008:administration & dosage; D006801:Humans; D007121:Immunocompetence; D007153:Immunologic Deficiency Syndromes / Q000276:immunology; D007167:Immunotherapy / Q000009:adverse effects; D007978:Levamisole / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000276:immunology / Q000628:therapy*; D008722:Methods; D009163:Mycobacterium bovis / Q000276:immunology
D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D007978:Levamisole